Articles - 1i9y mentioned but not cited (3)
- Structure and biological activities of beta toxin from Staphylococcus aureus. Huseby M, Shi K, Brown CK, Digre J, Mengistu F, Seo KS, Bohach GA, Schlievert PM, Ohlendorf DH, Earhart CA. J Bacteriol 189 8719-8726 (2007)
- Kinetoplastid RNA editing involves a 3' nucleotidyl phosphatase activity. Niemann M, Kaibel H, Schlüter E, Weitzel K, Brecht M, Göringer HU. Nucleic Acids Res 37 1897-1906 (2009)
- A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations. Paesmans J, Martin E, Deckers B, Berghmans M, Sethi R, Loeys Y, Pardon E, Steyaert J, Verstreken P, Galicia C, Versées W. Elife 9 e64922 (2020)
Reviews citing this publication (23)
- Phosphoinositides: tiny lipids with giant impact on cell regulation. Balla T. Physiol Rev 93 1019-1137 (2013)
- The emerging field of lipidomics. Wenk MR. Nat Rev Drug Discov 4 594-610 (2005)
- PIP(2) and proteins: interactions, organization, and information flow. McLaughlin S, Wang J, Gambhir A, Murray D. Annu Rev Biophys Biomol Struct 31 151-175 (2002)
- Human apurinic/apyrimidinic endonuclease 1. Li M, Wilson DM. Antioxid Redox Signal 20 678-707 (2014)
- The molecular physiology of activity-dependent bulk endocytosis of synaptic vesicles. Clayton EL, Cousin MA. J Neurochem 111 901-914 (2009)
- Structure and function of the Lowe syndrome protein OCRL1. Lowe M. Traffic 6 711-719 (2005)
- Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL. Pirruccello M, De Camilli P. Trends Biochem Sci 37 134-143 (2012)
- Lipid phosphatases as drug discovery targets for type 2 diabetes. Lazar DF, Saltiel AR. Nat Rev Drug Discov 5 333-342 (2006)
- The cellular and physiological functions of the Lowe syndrome protein OCRL1. Mehta ZB, Pietka G, Lowe M. Traffic 15 471-487 (2014)
- The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases. Backers K, Blero D, Paternotte N, Zhang J, Erneux C. Adv Enzyme Regul 43 15-28 (2003)
- The extended human PTPome: a growing tyrosine phosphatase family. Alonso A, Pulido R. FEBS J 283 1404-1429 (2016)
- Inositol polyphosphate 5-phosphatases; new players in the regulation of cilia and ciliopathies. Conduit SE, Dyson JM, Mitchell CA. FEBS Lett 586 2846-2857 (2012)
- Regulation of the immune response by SHIP. March ME, Ravichandran K. Semin Immunol 14 37-47 (2002)
- Phosphoinositide phosphatases in a network of signalling reactions. Blero D, Payrastre B, Schurmans S, Erneux C. Pflugers Arch 455 31-44 (2007)
- The structure of phosphoinositide phosphatases: Insights into substrate specificity and catalysis. Hsu F, Mao Y. Biochim Biophys Acta 1851 698-710 (2015)
- The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious Toxin. Scuron MD, Boesze-Battaglia K, Dlakić M, Shenker BJ. Front Cell Infect Microbiol 6 168 (2016)
- PTEN and Other PtdIns(3,4,5)P3 Lipid Phosphatases in Breast Cancer. Csolle MP, Ooms LM, Papa A, Mitchell CA. Int J Mol Sci 21 E9189 (2020)
- Pleiotropic functions of EAPII/TTRAP/TDP2: cancer development, chemoresistance and beyond. Li C, Sun SY, Khuri FR, Li R. Cell Cycle 10 3274-3283 (2011)
- Regulation of Golgi function via phosphoinositide lipids. Mayinger P. Semin Cell Dev Biol 20 793-800 (2009)
- Phosphatidylinositolphosphate phosphatase activities and cancer. Rudge SA, Wakelam MJ. J Lipid Res 57 176-192 (2016)
- Structural genomics and signaling domains. Hurley JH, Anderson DE, Beach B, Canagarajah B, Ho YS, Jones E, Miller G, Misra S, Pearson M, Saidi L, Suer S, Trievel R, Tsujishita Y. Trends Biochem Sci 27 48-53 (2002)
- The role of lipids in autophagy and its implication in neurodegeneration. Hernandez-Diaz S, Soukup SF. Cell Stress 4 167-186 (2020)
- SHIP1/2 interaction with tyrosine phosphorylated peptides mimicking an immunoreceptor signalling motif. Pesesse X, Backers K, Moreau C, Zhang J, Blero D, Paternotte N, Erneux C. Adv Enzyme Regul 46 142-153 (2006)
Articles citing this publication (56)
- Rapid chemically induced changes of PtdIns(4,5)P2 gate KCNQ ion channels. Suh BC, Inoue T, Meyer T, Hille B. Science 314 1454-1457 (2006)
- Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Bielas SL, Silhavy JL, Brancati F, Kisseleva MV, Al-Gazali L, Sztriha L, Bayoumi RA, Zaki MS, Abdel-Aleem A, Rosti RO, Kayserili H, Swistun D, Scott LC, Bertini E, Boltshauser E, Fazzi E, Travaglini L, Field SJ, Gayral S, Jacoby M, Schurmans S, Dallapiccola B, Majerus PW, Valente EM, Gleeson JG. Nat Genet 41 1032-1036 (2009)
- Phosphoinositides Regulate Ciliary Protein Trafficking to Modulate Hedgehog Signaling. Garcia-Gonzalo FR, Phua SC, Roberson EC, Garcia G, Abedin M, Schurmans S, Inoue T, Reiter JF. Dev Cell 34 400-409 (2015)
- A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. Erdmann KS, Mao Y, McCrea HJ, Zoncu R, Lee S, Paradise S, Modregger J, Biemesderfer D, Toomre D, De Camilli P. Dev Cell 13 377-390 (2007)
- The yeast synaptojanin-like proteins control the cellular distribution of phosphatidylinositol (4,5)-bisphosphate. Stefan CJ, Audhya A, Emr SD. Mol Biol Cell 13 542-557 (2002)
- The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals. Mani M, Lee SY, Lucast L, Cremona O, Di Paolo G, De Camilli P, Ryan TA. Neuron 56 1004-1018 (2007)
- OCRL controls trafficking through early endosomes via PtdIns4,5P₂-dependent regulation of endosomal actin. Vicinanza M, Di Campli A, Polishchuk E, Santoro M, Di Tullio G, Godi A, Levtchenko E, De Leo MG, Polishchuk R, Sandoval L, Marzolo MP, De Matteis MA. EMBO J 30 4970-4985 (2011)
- The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals. Vanhauwaert R, Kuenen S, Masius R, Bademosi A, Manetsberger J, Schoovaerts N, Bounti L, Gontcharenko S, Swerts J, Vilain S, Picillo M, Barone P, Munshi ST, de Vrij FM, Kushner SA, Gounko NV, Mandemakers W, Bonifati V, Meunier FA, Soukup SF, Verstreken P. EMBO J 36 1392-1411 (2017)
- A distinct pool of phosphatidylinositol 4,5-bisphosphate in caveolae revealed by a nanoscale labeling technique. Fujita A, Cheng J, Tauchi-Sato K, Takenawa T, Fujimoto T. Proc Natl Acad Sci U S A 106 9256-9261 (2009)
- The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. Dyson JM, O'Malley CJ, Becanovic J, Munday AD, Berndt MC, Coghill ID, Nandurkar HH, Ooms LM, Mitchell CA. J Cell Biol 155 1065-1079 (2001)
- Cotyledon vascular pattern2-mediated inositol (1,4,5) triphosphate signal transduction is essential for closed venation patterns of Arabidopsis foliar organs. Carland FM, Nelson T. Plant Cell 16 1263-1275 (2004)
- Type II phosphoinositide 5-phosphatases have unique sensitivities towards fatty acid composition and head group phosphorylation. Schmid AC, Wise HM, Mitchell CA, Nussbaum R, Woscholski R. FEBS Lett 576 9-13 (2004)
- From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hichri H, Rendu J, Monnier N, Coutton C, Dorseuil O, Poussou RV, Baujat G, Blanchard A, Nobili F, Ranchin B, Remesy M, Salomon R, Satre V, Lunardi J. Hum Mutat 32 379-388 (2011)
- Heme-assisted S-nitrosation of a proximal thiolate in a nitric oxide transport protein. Weichsel A, Maes EM, Andersen JF, Valenzuela JG, Shokhireva TKh, Walker FA, Montfort WR. Proc Natl Acad Sci U S A 102 594-599 (2005)
- A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism. Mao Y, Balkin DM, Zoncu R, Erdmann KS, Tomasini L, Hu F, Jin MM, Hodsdon ME, De Camilli P. EMBO J 28 1831-1842 (2009)
- A Vibrio effector protein is an inositol phosphatase and disrupts host cell membrane integrity. Broberg CA, Zhang L, Gonzalez H, Laskowski-Arce MA, Orth K. Science 329 1660-1662 (2010)
- A novel mode of action for a microbial-derived immunotoxin: the cytolethal distending toxin subunit B exhibits phosphatidylinositol 3,4,5-triphosphate phosphatase activity. Shenker BJ, Dlakic M, Walker LP, Besack D, Jaffe E, LaBelle E, Boesze-Battaglia K. J Immunol 178 5099-5108 (2007)
- A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1. Hou X, Hagemann N, Schoebel S, Blankenfeldt W, Goody RS, Erdmann KS, Itzen A. EMBO J 30 1659-1670 (2011)
- Dissecting the role of PtdIns(4,5)P2 in endocytosis and recycling of the transferrin receptor. Abe N, Inoue T, Galvez T, Klein L, Meyer T. J Cell Sci 121 1488-1494 (2008)
- Crystal structure of the catalytic core of inositol 1,4,5-trisphosphate 3-kinase. Miller GJ, Hurley JH. Mol Cell 15 703-711 (2004)
- Crystal structure of the targeting endonuclease of the human LINE-1 retrotransposon. Weichenrieder O, Repanas K, Perrakis A. Structure 12 975-986 (2004)
- Regulation of phagocytosis in Dictyostelium by the inositol 5-phosphatase OCRL homolog Dd5P4. Loovers HM, Kortholt A, de Groote H, Whitty L, Nussbaum RL, van Haastert PJ. Traffic 8 618-628 (2007)
- Functional characterization of XendoU, the endoribonuclease involved in small nucleolar RNA biosynthesis. Gioia U, Laneve P, Dlakic M, Arceci M, Bozzoni I, Caffarelli E. J Biol Chem 280 18996-19002 (2005)
- Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer. Ben-Chetrit N, Chetrit D, Russell R, Körner C, Mancini M, Abdul-Hai A, Itkin T, Carvalho S, Cohen-Dvashi H, Koestler WJ, Shukla K, Lindzen M, Kedmi M, Lauriola M, Shulman Z, Barr H, Seger D, Ferraro DA, Pareja F, Gil-Henn H, Lapidot T, Alon R, Milanezi F, Symons M, Ben-Hamo R, Efroni S, Schmitt F, Schmitt F, Wiemann S, Caldas C, Ehrlich M, Yarden Y. Sci Signal 8 ra7 (2015)
- Phosphatidylinositol 3-phosphate [PtdIns3P] is generated at the plasma membrane by an inositol polyphosphate 5-phosphatase: endogenous PtdIns3P can promote GLUT4 translocation to the plasma membrane. Kong AM, Horan KA, Sriratana A, Bailey CG, Collyer LJ, Nandurkar HH, Shisheva A, Layton MJ, Rasko JE, Rowe T, Mitchell CA. Mol Cell Biol 26 6065-6081 (2006)
- Comparative modeling in CASP5: progress is evident, but alignment errors remain a significant hindrance. Venclovas C. Proteins 53 Suppl 6 380-388 (2003)
- Structural basis for phosphoinositide substrate recognition, catalysis, and membrane interactions in human inositol polyphosphate 5-phosphatases. Trésaugues L, Silvander C, Flodin S, Welin M, Nyman T, Gräslund S, Hammarström M, Berglund H, Nordlund P. Structure 22 744-755 (2014)
- Expression and activity of the cytolethal distending toxin of Helicobacter hepaticus. Avenaud P, Castroviejo M, Claret S, Rosenbaum J, Mégraud F, Ménard A. Biochem Biophys Res Commun 318 739-745 (2004)
- Molecular characterization of an Arabidopsis gene encoding a phospholipid-specific inositol polyphosphate 5-phosphatase. Ercetin ME, Gillaspy GE. Plant Physiol 135 938-946 (2004)
- Inositol polyphosphate phosphatidylinositol 5-phosphatase9 (At5ptase9) controls plant salt tolerance by regulating endocytosis. Golani Y, Kaye Y, Gilhar O, Ercetin M, Gillaspy G, Levine A. Mol Plant 6 1781-1794 (2013)
- Polyunsaturated fatty acids influence synaptojanin localization to regulate synaptic vesicle recycling. Marza E, Long T, Saiardi A, Sumakovic M, Eimer S, Hall DH, Lesa GM. Mol Biol Cell 19 833-842 (2008)
- Synaptojanin cooperates in vivo with endophilin through an unexpected mechanism. Dong Y, Gou Y, Li Y, Liu Y, Bai J. Elife 4 (2015)
- A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discovery. Mills SJ, Persson C, Cozier G, Thomas MP, Trésaugues L, Erneux C, Riley AM, Nordlund P, Potter BV. ACS Chem Biol 7 822-828 (2012)
- The toxicity of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin correlates with its phosphatidylinositol-3,4,5-triphosphate phosphatase activity. Shenker BJ, Boesze-Battaglia K, Scuron MD, Walker LP, Zekavat A, Dlakić M. Cell Microbiol 18 223-243 (2016)
- Regulation of FcgammaR-stimulated phagocytosis by the 72-kDa inositol polyphosphate 5-phosphatase: SHIP1, but not the 72-kDa 5-phosphatase, regulates complement receptor 3 mediated phagocytosis by differential recruitment of these 5-phosphatases to the phagocytic cup. Horan KA, Watanabe K, Kong AM, Bailey CG, Rasko JE, Sasaki T, Mitchell CA. Blood 110 4480-4491 (2007)
- Identification of inhibitors of inositol 5-phosphatases through multiple screening strategies. Pirruccello M, Nandez R, Idevall-Hagren O, Alcazar-Roman A, Abriola L, Berwick SA, Lucast L, Morel D, De Camilli P. ACS Chem Biol 9 1359-1368 (2014)
- Structural and functional characterization of the kindlin-1 pleckstrin homology domain. Yates LA, Lumb CN, Brahme NN, Zalyte R, Bird LE, De Colibus L, Owens RJ, Calderwood DA, Sansom MS, Gilbert RJ. J Biol Chem 287 43246-43261 (2012)
- A Novel SYNJ1 Mutation in a Tunisian Family with Juvenile Parkinson's Disease Associated with Epilepsy. Ben Romdhan S, Sakka S, Farhat N, Triki S, Dammak M, Mhiri C. J Mol Neurosci 66 273-278 (2018)
- Investigation of the role of the histidine-aspartate pair in the human exonuclease III-like abasic endonuclease, Ape1. Lowry DF, Hoyt DW, Khazi FA, Bagu J, Lindsey AG, Wilson DM. J Mol Biol 329 311-322 (2003)
- A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1). Zhang J, Ravichandran KS, Garrison JC. J Biol Chem 285 34839-34849 (2010)
- Phosphoinositides regulate the TCR/CD3 complex membrane dynamics and activation. Chouaki Benmansour N, Ruminski K, Sartre AM, Phelipot MC, Salles A, Bergot E, Wu A, Chicanne G, Fallet M, Brustlein S, Billaudeau C, Formisano A, Mailfert S, Payrastre B, Marguet D, Brasselet S, Hamon Y, He HT. Sci Rep 8 4966 (2018)
- 3-hydroxybenzene 1,2,4-trisphosphate, a novel second messenger mimic and unusual substrate for type-I myo-inositol 1,4,5-trisphosphate 5-phosphatase: Synthesis and physicochemistry. Mills SJ, Dozol H, Vandeput F, Backers K, Woodman T, Erneux C, Spiess B, Potter BV. Chembiochem 7 1696-1706 (2006)
- A high-throughput microfluidic assay for SH2 domain-containing inositol 5-phosphatase 2. Rowe T, Hale C, Zhou A, Kurzeja RJ, Ali A, Menjares A, Wang M, McCarter JD. Assay Drug Dev Technol 4 175-183 (2006)
- Crystal Structures of Type-II Inositol Polyphosphate 5-Phosphatase INPP5B with Synthetic Inositol Polyphosphate Surrogates Reveal New Mechanistic Insights for the Inositol 5-Phosphatase Family. Mills SJ, Silvander C, Cozier G, Trésaugues L, Nordlund P, Potter BV. Biochemistry 55 1384-1397 (2016)
- SdhA blocks disruption of the Legionella-containing vacuole by hijacking the OCRL phosphatase. Choi WY, Kim S, Aurass P, Huo W, Creasey EA, Edwards M, Lowe M, Isberg RR. Cell Rep 37 109894 (2021)
- Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease. Tariq K, Luikart BW. Explor Neuroprotective Ther 1 86-100 (2021)
- Activation of PLC by an endogenous cytokine (GBP) in Drosophila S3 cells and its application as a model for studying inositol phosphate signalling through ITPK1. Zhou Y, Wu S, Wang H, Hayakawa Y, Bird GS, Bird GS, Shears SB. Biochem J 448 273-283 (2012)
- Expansion and Functional Divergence of Inositol Polyphosphate 5-Phosphatases in Angiosperms. Zhang Z, Li Y, Luo Z, Kong S, Zhao Y, Zhang C, Zhang W, Yuan H, Cheng L. Genes (Basel) 10 E393 (2019)
- Membrane interaction and functional plasticity of inositol polyphosphate 5-phosphatases. Braun W, Schein CH. Structure 22 664-666 (2014)
- Screening assay for small-molecule inhibitors of synaptojanin 1, a synaptic phosphoinositide phosphatase. McIntire LB, Lee KI, Chang-Ileto B, Di Paolo G, Kim TW. J Biomol Screen 19 585-594 (2014)
- Taking U out, with two nucleases? Mian IS, Worthey EA, Salavati R. BMC Bioinformatics 7 305 (2006)
- A positive feedback loop between Flower and PI(4,5)P2 at periactive zones controls bulk endocytosis in Drosophila. Li TN, Chen YJ, Lu TY, Wang YT, Lin HC, Yao CK. Elife 9 e60125 (2020)
- Novel mutation in OCRL leading to a severe form of Lowe syndrome. Zhou FQ, Wang QW, Liu ZZ, Zhang XL, Wang DN, Dongye MM, Lin HT, Chen WR. Int J Ophthalmol 12 1057-1060 (2019)
- Genotype & phenotype in Lowe Syndrome: specific OCRL1 patient mutations differentially impact cellular phenotypes. Ramadesikan S, Skiba L, Lee J, Madhivanan K, Sarkar D, De La Fuente A, Hanna CB, Terashi G, Hazbun T, Kihara D, Aguilar RC. Hum Mol Genet 30 198-212 (2021)
- Combining data integration and molecular dynamics for target identification in α-Synuclein-aggregating neurodegenerative diseases: Structural insights on Synaptojanin-1 (Synj1). Jenkins K, Mateeva T, Szabó I, Melnik A, Picotti P, Csikász-Nagy A, Rosta E. Comput Struct Biotechnol J 18 1032-1042 (2020)
- Expression and purification in high yield of a functionally active recombinant human Type I inositol(1,4,5)P3 5-phosphatase. Wohlkönig A, Sénéchal M, Dewitte F, Backers K, Erneux C, Villeret V. Protein Expr Purif 55 69-74 (2007)